Skye Bioscience (SKYE) Institutional Ownership $3.50 -0.05 (-1.41%) As of 09:33 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Skye Bioscience (NASDAQ:SKYE)CurrentInstitutional OwnershipPercentage21.09%Number ofInstitutional Buyers(last 12 months)29TotalInstitutional Inflows(last 12 months)$78.61MNumber ofInstitutional Sellers(last 12 months)12TotalInstitutional Outflows(last 12 months)$5.04M Get SKYE Insider Trade Alerts Want to know when executives and insiders are buying or selling Skye Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SKYE Institutional Buying and Selling by Quarter Skye Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/1/2025 Y Intercept Hong Kong Ltd10,046$42K0.0%N/A0.032% 6/27/2025Goldman Sachs Group Inc.43,491$69K0.0%-38.8%0.140% 5/16/2025Goldman Sachs Group Inc.43,491$69K0.0%-38.8%0.140% 5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.310,013$493K0.0%-5.0%1.001% 5/15/2025Driehaus Capital Management LLC620,395$986K0.0%-4.7%2.003% 5/13/2025Altium Capital Management LLC904,865$1.44M3.5%-20.6%2.921% 5/12/2025Nuveen LLC23,389$37K0.0%N/A0.076% 4/25/2025Capital Advisors Wealth Management LLC20,900$33K0.0%N/A0.067% 2/17/2025Squarepoint Ops LLC13,546$38K0.0%N/A0.045% 2/17/2025Two Sigma Advisers LP11,200$32K0.0%N/A0.037% Get the Latest News and Ratings for SKYE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Skye Bioscience and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.326,241$923K0.0%-5.3%1.075% 2/17/2025Ensign Peak Advisors Inc767,287$2.17M0.0%-14.7%2.529% 2/17/2025Deutsche Bank AG40,835$116K0.0%+365.0%0.135% 2/17/2025Bridgeway Capital Management LLC72,000$204K0.0%+26.3%0.237% 2/17/2025Braidwell LP825,732$2.34M0.1%N/A2.722% 2/17/2025Baker BROS. Advisors LP1,450,638$4.11M0.0%+1.1%4.781% 2/17/2025Bank of America Corp DE39,257$111K0.0%+37.4%0.129% 2/17/2025BNP Paribas Financial Markets31,637$90K0.0%-33.3%0.104% 2/17/2025Alyeska Investment Group L.P.456,163$1.29M0.0%-17.7%1.504% 2/14/2025Jane Street Group LLC36,057$102K0.0%+195.5%0.119% 2/14/2025Schonfeld Strategic Advisors LLC1,422,741$4.03M0.0%+48.3%4.689% 2/14/2025 AdvisorShares Investments LLC88,391$250K0.0%-23.1%0.291% 2/14/2025Northern Trust Corp135,712$384K0.0%-3.7%0.447% 2/14/2025Altium Capital Management LLC1,139,000$3.22M0.9%-13.4%3.754% 2/13/2025Barclays PLC69,620$198K0.0%+20.3%0.229% 2/13/2025Wells Fargo & Company MN11,199$32K0.0%+49.0%0.037% 2/12/2025Geode Capital Management LLC405,694$1.15M0.0%+5.2%1.337% 2/11/2025Virtu Financial LLC10,142$29K0.0%N/A0.033% 2/11/2025 Platinum Investment Management Ltd.434,046$1.23M0.1%-10.5%1.431% 2/6/2025Charles Schwab Investment Management Inc.62,363$176K0.0%+20.7%0.206% 1/1/2025JPMorgan Chase & Co.11,362$44K0.0%-24.1%0.037% 11/19/2024Barclays PLC57,889$226K0.0%+36.7%0.191% 11/16/2024Geode Capital Management LLC385,793$1.51M0.0%+4.2%1.272% 11/15/2024Barclays PLC57,889$226K0.0%+36.7%0.191% 11/15/2024Jane Street Group LLC12,200$48K0.0%N/A0.040% 11/15/2024Sphera Funds Management LTD.1,563,522$6.11M1.0%+20.4%5.153% 11/15/2024State Street Corp354,205$1.39M0.0%+7.0%1.167% 11/15/2024Point72 Asset Management L.P.416,424$1.63M0.0%-25.6%1.373% 11/15/2024Baker BROS. Advisors LP1,434,634$5.61M0.1%+186.9%4.729% 11/13/2024BNP Paribas Financial Markets47,417$185K0.0%+71.1%0.156% Protect Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late.9/16/2024Point72 DIFC Ltd6,000$48K0.0%N/A0.021% 9/16/2024Cubist Systematic Strategies LLC3,762$30K0.0%N/A0.013% 9/16/2024Point72 Asia Singapore Pte. Ltd.27,768$222K0.0%N/A0.099% 8/19/2024Point72 Asset Management L.P.560,000$4.49M0.0%N/A1.995% 8/16/2024Perceptive Advisors LLC500,000$4.01M0.1%N/A1.781% 8/16/2024Driehaus Capital Management LLC650,758$5.21M0.0%N/A2.319% 8/15/2024CVI Holdings LLC679,739$5.45M4.9%N/A2.422% 8/15/2024Point72 Asia Singapore Pte. Ltd.27,768$222K0.0%N/A0.099% 8/14/2024Cubist Systematic Strategies LLC3,762$30K0.0%N/A0.013% 8/14/2024Point72 DIFC Ltd6,000$48K0.0%N/A0.021% 8/14/2024Logos Global Management LP1,301,518$10.43M0.8%N/A4.637% 8/8/2024 AdvisorShares Investments LLC26,000$210K0.0%N/A0.093% 8/1/2024Rhumbline Advisers19,754$158K0.0%N/A0.070% 7/26/2024 Bank of New York Mellon Corp58,778$471K0.0%N/A0.209% (Data available from 1/1/2016 forward) SKYE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SKYE shares? During the previous two years, 39 institutional investors and hedge funds held shares of Skye Bioscience. The most heavily invested institutionals were Logos Global Management LP ($10.43M), Sphera Funds Management LTD. ($6.11M), CVI Holdings LLC ($5.45M), Baker BROS. Advisors LP ($4.11M), Schonfeld Strategic Advisors LLC ($4.03M), Perceptive Advisors LLC ($4.01M), and Braidwell LP ($2.34M).Learn more on Skye Bioscience's institutional investors. What percentage of Skye Bioscience's stock is owned by institutional investors? 21.09% of Skye Bioscience's stock is owned by institutional investors. Learn more on SKYE's institutional investor holdings. Which institutional investors have been buying Skye Bioscience's stock? Of the 31 institutional investors that purchased Skye Bioscience's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Logos Global Management LP ($1.30M), Baker BROS. Advisors LP ($950.64K), Braidwell LP ($825.73K), CVI Holdings LLC ($679.74K), Driehaus Capital Management LLC ($650.76K), Point72 Asset Management L.P. ($560K), and Perceptive Advisors LLC ($500K). How much institutional buying is happening at Skye Bioscience? Institutional investors have bought a total of 6,590,973 shares in the last 24 months. This purchase volume represents approximately $78.61M in transactions. Which of Skye Bioscience's major shareholders have been selling company stock? Of the 12 institutional investors that sold Skye Bioscience's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Altium Capital Management LLC ($410.28K), Point72 Asset Management L.P. ($143.58K), Ensign Peak Advisors Inc ($132.71K), Alyeska Investment Group L.P. ($98.01K), Goldman Sachs Group Inc. ($55.18K), Platinum Investment Management Ltd. ($51.15K), and MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. ($34.44K). How much institutional selling is happening at Skye Bioscience? Institutional investors have sold a total of 1,006,885 shares in the last 24 months. This volume of shares sold represents approximately $5.04M in transactions. Related Companies GOSS Major Shareholders ERAS Major Shareholders CMPX Major Shareholders KMDA Major Shareholders PVLA Major Shareholders RGNX Major Shareholders TECX Major Shareholders KOD Major Shareholders FULC Major Shareholders CMPS Major Shareholders This page (NASDAQ:SKYE) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Skye Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Skye Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.